Are you Dr. Beilke?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 34 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
Division Of Infectious Diseases
Milwaukee, WI 53226Phone+1 414-805-0746Fax+1 414-805-0748
Summary
- Dr. Mark Beilke, MD is an infectious disease specialist in Milwaukee, Wisconsin. He is currently licensed to practice medicine in Wisconsin. He is affiliated with Froedtert and the Medical College of Wisconsin Froedtert Hospital and Clement J. Zablocki Veterans' Administration Medical Center.
Education & Training
Medical College of Wisconsin Affiliated HospitalsFellowship, Infectious Disease, 1985 - 1987
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1982 - 1985- University of Illinois College of MedicineClass of 1982
Certifications & Licensure
WI State Medical License 1985 - 2021
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Respiratory Virus Hospitalization Study (FLU 003 Plus) Start of enrollment: 2009 Aug 01
Publications & Presentations
PubMed
- 8 citationsProlonged oral antibiotic suppression in osteomyelitis and associated outcomes in a Veterans population.Michael Nowak, Jamie S. Winner, Mark A. Beilke
American Journal of Health-System Pharmacy. 2015-12-01 - 14 citationsHigh levels of CC-chemokine expression and downregulated levels of CCR5 during HIV-1/HTLV-1 and HIV-1/HTLV-2 coinfections.Z. Oo, C. S. Barrios, L. Castillo, M. A. Beilke
Journal of Medical Virology. 2015-05-01 - 8 citationsHuman T cell leukaemia virus type 2 tax protein mediates CC-chemokine expression in peripheral blood mononuclear cells via the nuclear factor kappa B canonical pathway.C. S. Barrios, L. Castillo, H. Zhi, Chou-Zen Giam, M. A. Beilke
Clinical and Experimental Immunology. 2014-01-01
Grant Support
- Immunomodulatory Function Of Human T Cell Leukemia Virus Type 2 (Htlv-2)Veterans Affairs2011–2012
- HIV, HTLV And Drug AbuseNational Center For Research Resources2005–2008
- Retroviral Co-Infections: HIV, HTLV And Drug AbuseNational Institute Of Allergy And Infectious Diseases2006
- Retroviral Co-Infections: HIV, HTLV And Drug AbuseNational Center For Research Resources2004–2006
- Retroviral Co-Infections: HIV, HTLV And Drug AbuseNational Institute Of Allergy And Infectious Diseases2002–2006
- Experimental Transmission Of HTLV-I To Nonhuman PrimateNational Center For Research Resources2003–2005
- Experimental Transmission Of HTLV I To NON Human PrimateNational Center For Research Resources1999–2002
- Monitoring CMV Viral LoadsNational Center For Research Resources1998–2001
- Gulf South Retroviral Coinfection ClinicNational Center For Research Resources1997–2001
- Experimental Transmission Of HTLV I To NON Human Primate: SIVNational Center For Research Resources1998
- Macaque Model Of HTLV I InfectionNational Center For Research Resources1997
- Prospective Study Of HTLV I And HTLV II Infected Patients With And Without HIV-1National Center For Research Resources1996–1997
